About Englewood Hospital and Medical Center

News

2009 Press Releases

15 Years of Leadership in Bloodless Medicine and Surgery

03/10/2009

Newly renamed Institute for Patient Blood Management and Bloodless Medicine and Surgery is a pioneer in transfusion-free medicine and surgery, a practice gaining increased attention from medical community amidst  growing evidence of transfusion-associated risks.

The Institute for Patient Blood Management and Bloodless Medicine and Surgery (formerly the New Jersey Institute for Bloodless Medicine and Surgery) at Englewood Hospital and Medical Center celebrates its 15th anniversary this year. The new name reflects the Institute’s commitment to the comprehensive management of patient blood and blood products to improve patient outcomes.

Since its inception of the Institute in 1994, Englewood Hospital has established itself as a world-recognized leader in patient blood management. This initiative, which is gaining increased attention from the global medical community, seeks to reduce the risks and costs associated with blood transfusion by providing effective alternatives.

Medical professionals from leading institutions such as the Cleveland Clinic, John Hopkins, and Massachusetts General and others from the U.S. and abroad have come to the Medical Center to learn how Englewood Hospital physicians use proven, effective alternatives to transfusion to improve patient outcomes. In fact, the U.S. government has consulted with Englewood Hospital to learn how to apply blood management techniques in dealing with catastrophic situations when little or no blood is available.

Today, a number of factors are driving increased interest in Patient Blood Management in the medical community.

Transfusion-associated risks are many. Although concerns about transfusion-transmitted AIDS and hepatitis have been all but eradicated thanks to more extensive and sophisticated testing, many negative outcomes are still associated with blood transfusion. These include viral, bacterial, and parasitic infections; conditions such as transfusion-related lung injury (TRALI); and increased complications and death rates.

Costs of blood transfusion continue to rise. Blood supply in shrinking, due to stringent parameters for which blood is accepted. At the same time, demand is growing, due to increasingly complex surgical procedures and an aging population. This leads to an inadequate blood supply and increasing costs.

“Given the range of transfusion-associated risks, transfusion should no longer be used as the default procedure for treating or preventing anemia before, during or after surgery,” noted Aryeh Shander, MD, Chief of Anesthesiology, Critical Care Medicine and Hyperbaric Medicine at Englewood Hospital and Medical Center and Executive Medical Director of the Institute for Patient Blood Management and Bloodless Medicine and Surgery. “There are highly effective alternatives to blood transfusion available that we use here at Englewood Hospital very successfully, with significantly improved patient outcomes.”

“A strong commitment to the practice of bloodless medicine and surgery is one of the key reasons why Englewood Hospital has such excellent cardiac outcomes,” said Richard Goldweit, MD, FACC, Chief of Cardiology at Englewood Hospital.

Englewood Hospital was number one in New Jersey and number three nationwide for patient 30-day heart attack survival, according to a 2008 study by the Centers for Medicare and Medicaid Services. The Medical Center’s mortality rates for coronary bypass surgery are among the lowest in the state, with a 100% survival rate on three of the last four Cardiac Report Cards issued by the NJ Department of Health and Senior Services.

“In addition to preventing bleeding during procedures, advanced planning and follow up are crucial to maintain optimal blood counts and the best medical outcomes,” noted Dr. Goldweit.

Englewood Hospital’s Institute for Patient Blood Management and Bloodless Medicine and Surgery is at the forefront of a turning tide, as the medical community increases its focus on using effective alternatives to transfusion to control costs and improve patient outcomes.

About Aryeh Shander, MD:
Chief of Anesthesiology, Critical Care Medicine and Hyperbaric Medicine at Englewood Hospital and Medical Center, Aryeh Shander, MD, is Executive Medical Director of the Medical Center’s Institute for Patient Blood Management, which seeks to improve patient outcomes through the effective management of blood. Dr. Shander is an internationally respected expert and has authored numerous books and studies on blood management. He lectures in the U.S. and abroad and is a founding member of the Society for the Advancement of Blood Management (SABM).